Chemocentryx Historical Balance Sheet

CCXI -  USA Stock  

USD 34.47  2.61  7.04%

Trend analysis of Chemocentryx balance sheet accounts such as Accounts Payable of 13.9 M, Accumulated Other Comprehensive Income of 394.6 K or Total Assets of 208 M provides information on Chemocentryx's total assets, liabilities, and equity, which is the actual value of Chemocentryx to its prevalent stockholders. By breaking down trends over time using Chemocentryx balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Chemocentryx prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chemocentryx is a good buy for the upcoming year.
Continue to Trending Equities.

Chemocentryx Historical Statements 

 
Refresh
Share

About Chemocentryx Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Chemocentryx at a specified time, usually calculated after every quarter, six months, or one year. Chemocentryx Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Chemocentryx and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Chemocentryx currently owns. An asset can also be divided into two categories, current and non-current.

Chemocentryx Balance Sheet Chart

Chemocentryx Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Chemocentryx uses and utilizes its capital. It also shows what exactly a company owns and owes.
Chemocentryx Accumulated Other Comprehensive Income is most likely to increase significantly in the upcoming years. The last year's value of Accumulated Other Comprehensive Income was reported at 365,700. The current Assets Non Current is estimated to increase to about 43.1 M, while Total Assets are projected to decrease to roughly 208 M.

Total Assets

Total assets refers to the total amount of Chemocentryx assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Chemocentryx books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; [Intangibles]; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Current Assets

Current assets of Chemocentryx include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Chemocentryx. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Chemocentryx balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Chemocentryx books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Chemocentryx balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Chemocentryx current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Chemocentryx Accumulated Other Comprehensive Income is most likely to increase significantly in the upcoming years. The last year's value of Accumulated Other Comprehensive Income was reported at 365,700. The current Assets Non Current is estimated to increase to about 43.1 M, while Total Assets are projected to decrease to roughly 208 M.
 2018 2019 2020 2021 (projected)
Accounts Payable966 K1.53 M12.88 M13.89 M
Receivables2.06 M176 K137 K140.6 K

Chemocentryx balance sheet Correlations

-0.62-0.61-0.54-0.5-0.43-0.880.27-0.88-0.420.49-0.77-0.74-0.68-0.7-0.79-0.63-0.54-0.780.7
-0.620.660.560.650.530.72-0.280.720.31-0.210.640.550.540.630.690.580.710.85-0.34
-0.610.660.960.50.670.73-0.450.730.61-0.350.90.870.580.890.890.880.890.71-0.23
-0.540.560.960.250.640.68-0.440.680.59-0.460.810.880.390.910.890.920.820.59-0.18
-0.50.650.50.250.360.5-0.210.50.280.210.590.320.830.30.390.240.560.7-0.27
-0.430.530.670.640.360.78-0.120.780.27-0.430.40.360.350.690.650.70.690.62-0.16
-0.880.720.730.680.50.78-0.251.00.46-0.620.680.660.640.850.890.810.670.81-0.48
0.27-0.28-0.45-0.44-0.21-0.12-0.25-0.27-0.830.25-0.43-0.41-0.3-0.44-0.42-0.44-0.49-0.25-0.31
-0.880.720.730.680.50.781.0-0.270.48-0.620.690.660.640.850.890.820.670.81-0.46
-0.420.310.610.590.280.270.46-0.830.48-0.360.610.60.530.60.590.60.470.220.17
0.49-0.21-0.35-0.460.21-0.43-0.620.25-0.62-0.36-0.2-0.34-0.08-0.71-0.67-0.73-0.23-0.240.01
-0.770.640.90.810.590.40.68-0.430.690.61-0.20.950.720.750.810.70.760.71-0.48
-0.740.550.870.880.320.360.66-0.410.660.6-0.340.950.530.790.830.760.70.61-0.48
-0.680.540.580.390.830.350.64-0.30.640.53-0.080.720.530.480.560.430.50.58-0.34
-0.70.630.890.910.30.690.85-0.440.850.6-0.710.750.790.480.991.00.750.66-0.19
-0.790.690.890.890.390.650.89-0.420.890.59-0.670.810.830.560.990.970.770.74-0.3
-0.630.580.880.920.240.70.81-0.440.820.6-0.730.70.760.431.00.970.730.61-0.12
-0.540.710.890.820.560.690.67-0.490.670.47-0.230.760.70.50.750.770.730.81-0.16
-0.780.850.710.590.70.620.81-0.250.810.22-0.240.710.610.580.660.740.610.81-0.54
0.7-0.34-0.23-0.18-0.27-0.16-0.48-0.31-0.460.170.01-0.48-0.48-0.34-0.19-0.3-0.12-0.16-0.54
Click cells to compare fundamentals

Chemocentryx Account Relationship Matchups

Chemocentryx balance sheet Accounts

201620172018201920202021 (projected)
Accounts Payable671 K1.4 M966 K1.53 M12.88 M13.89 M
Accumulated Other Comprehensive Income(50 K)(119 K)(198 K)318 K365.7 K394.57 K
Total Assets155.87 M189.33 M183.31 M209.08 M240.45 M208.02 M
Current Assets148.69 M179.83 M181.38 M174.36 M200.52 M178.21 M
Assets Non Current7.18 M9.5 M1.93 M34.72 M39.93 M43.08 M
Cash and Equivalents12.02 M40.02 M28.09 M39.18 M45.06 M36.4 M
Cash and Equivalents USD12.02 M40.02 M28.09 M39.18 M45.06 M36.4 M
Shareholders Equity49.89 M79.27 M14.74 M66 M59.4 M64.92 M
Shareholders Equity USD49.89 M79.27 M14.74 M66 M59.4 M64.92 M
Investments111.74 M95.2 M148.9 M163.06 M187.52 M159.93 M
Investments Current105.74 M87.27 M148.9 M133.61 M153.65 M134.56 M
Investments Non Current5.01 M6 M7.93 M29.45 M33.87 M36.55 M
Total Liabilities105.98 M110.06 M168.57 M143.08 M164.55 M177.54 M
Current Liabilities38.34 M32.94 M64.4 M59.08 M67.94 M73.31 M
Liabilities Non Current67.65 M77.12 M104.18 M84 M96.6 M104.23 M
Trade and Non Trade Payables671 K1.4 M966 K1.53 M1.76 M1.45 M
Property Plant and Equipment Net905 K1.21 M1.54 M3.86 M4.44 M4.79 M
Accumulated Retained Earnings Deficit(307.06 M)(289.2 M)(374.5 M)(429.99 M)(386.99 M)(397.17 M)

Chemocentryx Investors Sentiment

The influence of Chemocentryx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemocentryx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - CCXI

Chemocentryx Investor Sentiment

Most of Macroaxis users are currently bullish on Chemocentryx. What is your opinion about investing in Chemocentryx? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Brickell Biotech. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.